These findings indicate that CD276 is the primary diagnostic biomarker, with the combined panel showing a numerical trend toward improvement but lacking statistical significance for the incremental benefit of adding DKK3 in this cohort of 40 patients per group.
← all excerpts
Evaluation of the Clinical Value of the Serological Markers CD276 and DKK3 in Gastric Cancer: A Case-Control Study.
2
—
—
The sentences
Both markers exhibited highly significant differential expressions between the groups, underscoring their potential as diagnostic biomarkers.